Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.892 USD | +0.55% | -2.60% | -34.86% |
Apr. 26 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.86% | 171M | |
-2.60% | 102B | |
+2.10% | 96.09B | |
+2.13% | 22.28B | |
-17.09% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.94% | 16.09B | |
+6.55% | 13.83B | |
+32.03% | 11.97B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- bluebird bio : BMO Capital Adjusts Bluebird Bio's Price Target to $35 From $31, Maintains Market Perform Rating